Alirocumab for hyperlipidemia: physiology of PCSK9...

Alirocumab for hyperlipidemia: physiology of PCSK9 inhibition, pharmacodynamics and Phase I and II clinical trial results of a PCSK9 monoclonal antibody

Roth, Eli M, Diller, Philip
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Language:
english
Journal:
Future Cardiology
DOI:
10.2217/fca.13.107
Date:
March, 2014
File:
PDF, 3.97 MB
english, 2014
Conversion to is in progress
Conversion to is failed